Leading Technology and Market Position. PositiveID’s M-BAND The M-BAND is positioned to capitalize on BioWatch Generation 3, which is the U.S. Government’s $3.1 billion program to detect the release of pathogens into the air as part of a defense against po tential terrorist attacks on ma jor American cities. The Company’s M-BAND is one of only two known technologies capable of addressing the requirements of BioWatch Gen-3, and the only one to complete field-testing both domestically and internationally in DHS’ BAND program.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.